Patents by Inventor Beth Anne-Szkudlarek Brown

Beth Anne-Szkudlarek Brown has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10226431
    Abstract: Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.
    Type: Grant
    Filed: June 9, 2016
    Date of Patent: March 12, 2019
    Assignee: REBIOTIX, INC.
    Inventors: Lee A. Jones, Courtney R. Jones, Beth Anne-Szkudlarek Brown, Joshua Erickson
  • Publication number: 20180289750
    Abstract: Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.
    Type: Application
    Filed: June 14, 2018
    Publication date: October 11, 2018
    Applicant: REBIOTIX, INC.
    Inventors: LEE A. JONES, COURTNEY R. JONES, BETH ANNE-SZKUDLAREK BROWN, JOSHUA ERICKSON, MESSAC CHE NEBA
  • Publication number: 20180243349
    Abstract: Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.
    Type: Application
    Filed: April 27, 2018
    Publication date: August 30, 2018
    Applicant: REBIOTIX, INC.
    Inventors: LEE A. JONES, COURTNEY R. JONES, BETH ANNE-SZKUDLAREK BROWN, JOSHUA ERICKSON
  • Publication number: 20180078586
    Abstract: Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.
    Type: Application
    Filed: November 30, 2017
    Publication date: March 22, 2018
    Applicant: REBIOTIX, INC.
    Inventors: LEE A. JONES, COURTNEY R. JONES, BETH ANNE-SZKUDLAREK BROWN, JOSHUA ERICKSON
  • Publication number: 20170327862
    Abstract: Quantification of the viable bacterial microorganisms in a drug product for delivery via a gastro-nasal tube, an enema and/or a capsule or tablet. A molecular-based approach, such as PMA (propidium monazide)-qPCR (quantitative polymerase chain reaction) assays may be useful for quantification of viable bacteria. By utilizing PMA treatment in combination with qPCR, the number of viable bacterial cells in the sample can be determined.
    Type: Application
    Filed: May 12, 2017
    Publication date: November 16, 2017
    Inventors: BETH ANNE-SZKUDLAREK BROWN, JOSHUA ERICKSON, MAYA BURROUGHS, IAN SINCLAIR, COURTNEY R. JONES
  • Publication number: 20170281581
    Abstract: A topical composition that includes L-arginine that is used as a sports health composition. The composition can further include forskolin. Disclosed is a method of using the topical composition.
    Type: Application
    Filed: March 30, 2017
    Publication date: October 5, 2017
    Inventors: Beth Anne-Szkudlarek Brown, Anthony Lemus, Marnie L. Peterson
  • Publication number: 20170258855
    Abstract: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
    Type: Application
    Filed: May 26, 2017
    Publication date: September 14, 2017
    Inventors: Lee A. Jones, Courtney R. Jones, Beth Anne-Szkudlarek Brown, Joshua Erickson
  • Publication number: 20170252303
    Abstract: Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.
    Type: Application
    Filed: May 19, 2017
    Publication date: September 7, 2017
    Inventors: LEE A. JONES, COURTNEY R. JONES, BETH ANNE-SZKUDLAREK BROWN, JOSHUA ERICKSON
  • Patent number: 9694039
    Abstract: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
    Type: Grant
    Filed: December 30, 2015
    Date of Patent: July 4, 2017
    Assignee: REBIOTIX, INC.
    Inventors: Lee A. Jones, Courtney R. Jones, Beth Anne-Szkudlarek Brown, Joshua Erickson
  • Publication number: 20160361263
    Abstract: Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.
    Type: Application
    Filed: June 9, 2016
    Publication date: December 15, 2016
    Inventors: LEE A. JONES, COURTNEY R. JONES, BETH ANNE-SZKUDLAREK BROWN, JOSHUA ERICKSON
  • Publication number: 20160113974
    Abstract: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
    Type: Application
    Filed: December 30, 2015
    Publication date: April 28, 2016
    Inventors: Lee A. Jones, Courtney R. Jones, Beth Anne-Szkudlarek Brown, Joshua Erickson